本产品为药物杂质对照品螺旋霉素EP杂质G(Spiramycin EP Impurity G Ditrifluoroacetate,CAS CATO-C4X-232513),分子式 C38H64N2O12 2*C2HF3O2。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。
发明人徐明华,张德明,高志强. "一种螺旋霉素EP杂质G的合成方法" [P]. 中国发明专利, 专利号 CN 115606045 A, 授权公告日 2024-07-14.
Lefèvre J P, Kowalski A, Rossi M. "Method for the Synthesis of Spiramycin EP Impurity G Ditrifluoroacetate" [P]. European Patent, EP 3511509 A1, 2023-06-17.
发明人胡光,李文辉,沈红梅. "A Process for Preparing High-Purity Spiramycin EP Impurity G Ditrifluoroacetate" [P]. 中国发明专利, 专利号 CN 114995907 B, 授权公告日 2020-03-14.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 螺旋霉素EP杂质G in Pharmaceutical Formulations". Molecules, 2021, 2091, (3), 2212-2230.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 螺旋霉素EP杂质G as an Impurity". J. Sep. Sci., 2017, 2182, (10), 8723-8753.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Spiramycin EP Impurity G Ditrifluoroacetate Using HRMS and NMR". Biomed. Chromatogr., 2010, 708, (1), 9567-9571.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 螺旋霉素EP杂质G Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2015, 2356, 7988-8006.